(Pharmamar) PharmaMar (PHM:MSE) has announced that PM1183 (lurbinectedin), its third molecule of marine origin and analogue of Yondelis®, will receive the trade name of Zepsyre.
############
Story Source: Materials provided by Scienmag
PharmaMar will commercialize PM1183 with the trade name of Zepsyre
Related Posts
Please login to join discussion
POPULAR NEWS
-
NYU Abu Dhabi researchers identify unique survival strategies adopted by fish in the world’s warmest waters
-
CHOP experts describe types of rashes associated with MIS-C
-
Scientists discover that a protein associated with neurodegenerative diseases is also linked to childhood brain cancer
-
Automatic design of metaheuristics: The future of optimization?